Disease/Condition
525 Clinical Trials
10+ Countries
Metastatic Breast Cancer Clinical Trials Database - Free Access to 525 Studies
Access comprehensive clinical trial information for Metastatic Breast Cancer through Pure Global AI's free database. This collection includes 525 clinical trials across multiple phases including Phase 2, N/A, Phase 1. Currently, 62 trials are actively recruiting participants.
Research for Metastatic Breast Cancer is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Fudan University and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
Phase 2
227N/A
133Phase 1
54Phase 3
49Early Phase 1
42By Status
Completed
246Terminated
67Recruiting
62Not yet recruit...
54Unknown
53Top Countries
United States of America148
China53
France25
Germany22
South Korea19
Top Sponsors
Fudan University17
Eli Lilly and Comp...14
Genentech, Inc.13
Novartis Pharmaceu...12
Pfizer10
Recent Trials
Latest clinical trials for Metastatic Breast Cancer
SLCTR_2012_003
Phase 3
Terminated
Phase III Trial of Vinorelbine+BIBW 2992 vs Vinorelbine+Herceptin in BC Patients After Failing Herceptin Treatment
Boehringer Ingelheim India (Pv...Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, France, Germany
NCT06417801
Not yet recr...
Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer.
AstraZenecaBrazil
NCT06409390
Phase 1
Recruiting
Pilot Study of Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
H. Lee Moffitt Cancer Center a...United States of America
NCT06408038
Not yet recr...
Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer
Institut Claudius RegaudFrance
NCT06383767
Phase 3
Not yet recr...
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Shanghai Escugen Biotechnology...China
NCT06369831
Phase 2
Not yet recr...
HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011
ABSCINT NV/SABelgium
NCT06377852
Phase 3
Not yet recr...
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
American Society of Clinical O...
NCT06343181
Recruiting
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
European Institute of OncologyItaly
NCT06321666
Recruitment ...
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
European Institute of OncologyItaly
NCT06342037
Phase 2
Not yet recr...
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
The Netherlands Cancer Institu...
NCT06308939
Phase 2
Not yet recr...
Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial
Zhejiang Cancer HospitalChina
NCT06320392
Recruitment ...
Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer
Ain Shams UniversityEgypt
NCT06151249
Phase 2
Not yet recr...
Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy
Chung Shan Medical University
NCT06110793
Phase 1/2
Not yet recr...
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Memorial Sloan Kettering Cance...United States of America
NCT06106711
Not yet recr...
The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).
Centro di Riferimento Oncologi...Italy
NCT06105684
Phase 2
Not yet recr...
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
University of Alabama at Birmi...United States of America
NCT06099769
Phase 2
Recruiting
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Memorial Sloan Kettering Cance...United States of America
NCT06081959
Phase 3
Not yet recr...
A Phase III Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer
Sichuan Kelun Pharmaceutical R...
NCT06083038
Recruiting
Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib
HealthPartners InstituteUnited States of America
NCT06076772
Not yet recr...
Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients
Assiut UniversitySaudi Arabia
About Metastatic Breast Cancer Research
Pure Global AI provides free access to 525 clinical trials studying Metastatic Breast Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Fudan University, Eli Lilly and Company, Genentech, Inc., among others.
Quick Facts
Total Trials525
Countries10+
Sponsors10+
Recruiting62